Serum ferritin in haemodialysis

Area of Science:

• Nephrology
• Hematology
• Clinical Chemistry

Background:

• Dialysis patients often experience iron deficiency due to blood loss and inflammation.
• Serum ferritin is a key indicator of iron storage, but its interpretation can be complex in chronic kidney disease.

Purpose of the Study:

• To evaluate serum ferritin levels in patients undergoing regular dialysis.
• To assess the relationship between serum ferritin and iron status in this population.
• To investigate the efficacy of iron administration in dialysis patients.

Main Methods:

• A rapid assay was used to measure serum ferritin levels.
• Patients undergoing regular dialysis (both new and old) were compared to control groups.
• Iron status was monitored during iron treatment, with distinctions made for administration routes.

Main Results:

• Mean serum ferritin values were significantly higher in dialysis patients compared to controls, especially in older patients.
• The typical variations in serum ferritin based on age and sex were absent in the dialysis patient group.
• Serum ferritin reflected tissue iron levels during iron treatment, except when administered intravenously.
• Despite achieving an acceptable rise in serum ferritin, the overall results of iron administration were poor.

Conclusions:

• Elevated serum ferritin in dialysis patients is likely due to iron loss and frequent transfusions, masking normal age and sex-related differences.
• Serum ferritin remains a useful marker for tissue iron, but its interpretation requires consideration of the dialysis context.
• Intravenous iron administration may influence serum ferritin levels differently than oral or intramuscular routes, and overall iron repletion efficacy remains a challenge.